A CDC advisory committee has unanimously recommended AstraZeneca’s RSV vaccine for infants who are younger than 8 months, according to an Aug. 3 press release.
Read the full post on Becker's Hospital Review - Healthcare News
CDC advisory committee recommends AstraZeneca's infant RSV vaccine
